Esketamine – July 2024

Esketamine; Nasal spray solution 28 mg in 0.2 mL (2 actuations); Spravato® – July 2024 – December 2024

  • Brand names:
    • Spravato®
  • Pharmaceutical Company:
    • JANSSEN-CILAG PTY LTD
  • Condition/Indication: Treatment resistant depression
  • Meeting Date: July 2024
Related Public Summary Documents

Last updated
30 May 2025